|
1
|
Oztuna F, Pehlivanlar M, Abul Y, Tekinbas
C, Ozoran Y and Ozlu T: Adult inflammatory myofibroblastic tumor of
the trachea: Case report and literature review. Respir Care.
58:e72–e76. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamamoto H: WHO Classification of Tumours
Editorial Board. Fibroblastic/myofibroblastic Tumors. WHO
Classification of Tumors of Soft Tissue and Bone. 5th edition.
International Agency for Research on Cancer; Lyon, France: pp.
109–112. 2020
|
|
3
|
Gleason BC and Hornick JL: Inflammatory
myofibroblastic tumours: Where are we now? J Clin Pathol.
61:428–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ding R, Li X, Zhu XM, Song QX, Fan QH,
Zhang ZH and Gong QX: Inflammatory myofibroblastic tumor arising
from soft tissues of extremities harboring a novel CLIP2-ALK
fusion. Pathol Int. 70:798–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu H, Lin J, Yang P, Shen H and Yang H:
Whether inflammatory myofibroblastic tumor of the thigh relapses
after surgical excision? Int J Clin Exp Med. 8:11584–11588.
2015.PubMed/NCBI
|
|
6
|
Mariño-Enríquez A, Wang WL, Roy A,
Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM and Hornick JL:
Epithelioid inflammatory myofibroblastic sarcoma: An aggressive
intra-abdominal variant of inflammatory myofibroblastic tumor with
nuclear membrane or perinuclear ALK. Am J Surg Pathol. 35:135–144.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Du X, Gao Y, Zhao H, Li B, Xue W and Wang
D: Clinicopathological analysis of epithelioid inflammatory
myofibroblastic sarcoma. Oncol Lett. 15:9317–9326. 2018.PubMed/NCBI
|
|
8
|
Sarmiento DE, Clevenger JA, Masters GA,
Bauer TL and Nam BT: Epithelioid inflammatory myofibroblastic
sarcoma: A case report. J Thorac Dis. 7:E513–E516. 2015.PubMed/NCBI
|
|
9
|
Lee JC, Li CF, Huang HY, Zhu MJ,
Mariño-Enríquez A, Lee CT, Ou WB, Hornick JL and Fletcher JA: ALK
oncoproteins in atypical inflammatory myofibroblastic tumours:
Novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic
sarcoma. J Pathol. 241:316–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Q, Kan Y, Zhao Y, He H and Kong L:
Epithelioid inflammatory myofibroblastic sarcoma treated with ALK
inhibitor: A case report and review of literature. Int J Clin Exp
Pathol. 8:15328–15332. 2015.PubMed/NCBI
|
|
11
|
Shukla PS and Mittal K: Inflammatory
myofibroblastic tumor in female genital tract. Arch Pathol Lab Med.
143:122–129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chougule A, Bal A, Das A, Agarwal R, Singh
N and Rao KL: A comparative study of inflammatory myofibroblastic
tumors and tumefactive IgG4-related inflammatory lesions: The
relevance of IgG4 plasma cells. Appl Immunohistochem Mol Morphol.
24:721–728. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu L, Li J, Liu C, Ding W, Lin F, Guo C
and Liu L: Pulmonary inflammatory myofibroblastic tumor versus
IgG4-related inflammatory pseudotumor: Differential diagnosis based
on a case series. J Thorac Dis. 9:598–609. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taylor MS, Chougule A, MacLeay AR, Kurzawa
P, Chebib I, Le L and Deshpande V: Morphologic overlap between
inflammatory myofibroblastic tumor and IgG4-related disease:
Lessons from next-generation sequencing. Am J Surg Pathol.
43:314–324. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pecoraro Y, Diso D, Anile M, Russo E,
Patella M and Venuta F: Primary inflammatory myofibroblastic tumor
of the trachea. Respirol Case Rep. 2:147–149. 2014.PubMed/NCBI
|
|
16
|
Wang S, Chen L, Cao Z, Mao X, Zhang L and
Wang B: Inflammatory myofibroblastic tumor of the lumbar spinal
canal: A Case Report With Literature Review. Medicine (Baltimore).
96:e64882017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sukov WR, Cheville JC, Carlson AW, Shearer
BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP and Ketterling
RP: Utility of ALK-1 protein expression and ALK rearrangements in
distinguishing inflammatory myofibroblastic tumor from malignant
spindle cell lesions of the urinary bladder. Mod Pathol.
20:592–603. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cook JR, Dehner LP, Collins MH, Ma Z,
Morris SW, Coffin CM and Hill DA: Anaplastic lymphoma kinase (ALK)
expression in the inflammatory myofibroblastic tumor: A comparative
immunohistochemical study. Am J Surg Pathol. 25:1364–1371. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mossé YP, Voss SD, Lim MS, Rolland D,
Minard CG, Fox E, Adamson P, Wilner K, Blaney SM and Weigel BJ:
Targeting ALK with crizotinib in pediatric anaplastic large cell
lymphoma and inflammatory myofibroblastic tumor: A children's
oncology group study. J Clin Oncol. 35:3215–3221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Watanabe H, Uruma T, Tazaki G, Tajiri T,
Kikuchi R, Itoh M, Aoshiba K and Nakamura H: Remission of
ALK-negative primary pulmonary inflammatory myofibroblastic tumor
on treatment with clarithromycin: A case report and review of the
literature. Oncol Lett. 11:1757–1761. 2016. View Article : Google Scholar : PubMed/NCBI
|
